Post 23: Getting Better at Treating the BioWeapons: Clinical Rationale for SARS-CoV-2 Base Spike Protein Detoxification in Post COVID-19 and Vaccine Injury Syndromes
The recent publication by Dr. McCullough in the Journal of American Physicians and Surgeons (2023) highlights the need and power of independent research and unbiased, open journals. Plan B in action.
The use of supplements and rapid-cycle clinical reporting of success and failures, has resulted in a real-world application of a treatment for the sequalae of “Long-COVID” and the removal of a “by-design“ long-lived, toxic protein fragment. The Spike Protein is at the heart of the damage that is produced by the SARS-CoV-2 virus and the mRNA-based gene therapies.
The use of proteolytic (protein chewing!) enzymes (nattokinase and bromelain) and immune modulating curcumin allows for graded and effective removal of the Spike-Proteins. The publication highlights that effective use of these supplements to stop and help remove the S-protein, allowing the opportunity for the body to heal.
After the S-Protein – What Can You Do?
Clotting, organ damage, micro-strokes, immune dysfunction and the accumulated damage from the virus and the jab that produce the symptoms of “long COVID” may take months to years to recover. Depending on age, health status and immune system function, the recovery may happen so slowly as to be negligible.
Yet, when you can clear the source of the damage (the S-protein), there are ways to speed up the healing and boost the body’s ability to recover. There are at least three simple and relatively low-cost ways to jump start recovery:
1. Hyperbaric Oxygen or hyperbaric air therapy
a. Supplementation with Omega-3 fatty acids
2. Intermittent fasting or 3-5 day fasting
3. N-acetyl Cysteine supplementation
I covered most of this on Post 8 (Waaaaay back in Jan 22, 2023)
Hyperbaric Oxygen/Hyperbaric Air Therapy
The literature in the field of hyperbaric oxygen therapy (HBOT) and more recently with hyperbaric air treatments (MacLaughlin et al, 2023), has demonstrated the ability to increase the number of stem progenitor cells (SPC) that are released into the blood. Why is this important?
SPCs come in two major flavors: SPCs released from bone marrow and SPCs released from local organ/vascular regions. Both are critical for injury and disease repair of organs and tissues.
In the HBOT literature, repeated treatment with HBOT (breathing 95%-100% oxygen) at a range of pressures (> 1.5 atmospheres absolute [ATA] and now air treatments, 21%-35% oxygen/79-65% nitrogen) produces a steady increase in the number of SPC in the blood stream. SPCs are essential for vasculogenesis, angiogenesis, neurogenesis and wound/injury repair for non-healing wounds.
In cases of active stroke, completed strokes, traumatic brain injury (TBI), burn injuries and diabetic foot ulcers HBOT has shown the ability to reverse neurological injury, reverse organ damage (depending on the organ), improve wound healing and close wounds. Hyperbaric air (HBAT; (MacLaughlin et al, 2023)) at 1.27 ATA has demonstrated the ability to mobilize SPCs and change the ratio of the pro-inflammatory cytokines (signaling molecules of the immune system). HBAT controls in animal and human studies have demonstrated improvements over true controls or baselines in stroke and human clinical trials of TBI. Although definitive studies have not been done to assess what is the optimum pressure regime for HBAT, it may serve an important role for symptom management and as an aid in healing, if HBOT is not available or priced beyond people’s means.
All these conditions have two major mechanisms of action for repair: SPCs and immune/inflammation regulation. When organs are injured, they produce inflammatory signal that attract SPCs to help in re-growing and repairing the damaged areas. Some organs, like the heart and brain, have trouble repairing the damage, but that could a function of treatment duration and appropriate support. With HBOT and HBAT, if you can elevate the number of circulating SPCs, the chances of them homing into the injury sites, and the increase in total available SPCs to work with, appear to accelerate or unblock repair of the injured organs.
HBOT as a treatment from SARs-CoV-2 injuries, especially heart and cognitive sequelae, have shown an ability to help in recovery from long-COVID symptoms. Given the similarity in the mechanism of injury from SARs-CoV-2 and the jabs, it is a reasonable assumption that HBOT and/or HBAT could help in recovery. An earlier report from the University Hospitals Coventry, UK (2021), assessing baseline (testing before treatment) versus post HBOT treatment, have shown that HBOT (2.4 ATA 100% oxygen) given 10 times over 12 days, saw statistically significant improvements in cognitive performance and fatigue improvements. Did 10 treatments fully resolve their symptoms? Probably not – but the improvements were sustained for weeks.
We had a similar experience with a population of 6 patients (Hyperbaric oxygen therapy to treat lingering COVID-19 symptoms), that saw significant and dramatic improvements in dyspnea, fatigue, joint & muscle pain and cognitive function with HBOT at 2.0 ATA (90 minutes per treatment). The results were incredible, but the number of treatments was on the higher side ( > 10), compared to the other published studies.
The HOT-LoCO trials, which is a full randomized, “placebo” controlled study, is designed to fail – in my modest opinion. Using 2.4 ATA (HBOT) and comparing the results to a “placebo” treatment – when in reality it is a different pressure and gas mix treatment (as shown by Dr. MacLaughlin’s work) – and only offering 10 treatments over 6 weeks. The results will be middling, with the potential of the placebo (HBAT: 1.34 ATA medical air) actually outperforming the HBOT treatment (HBOT: 2.4 ATA 100% oxygen).
Additionally, supplementation with Omega-3 fatty acid and Vitamin D has demonstrated the ability to aid in the recovery of brain injuries and in improving myocardial function/reducing scarring after stroke and heart failure in general. HBOT/HBAT, in combination with Omega-3 fatty acids and Vitamin D appear to be well-tolerated, safe and bear all the hallmarks of working synergistically to recover lost function and improve symptoms.
Intermittent Fasting
Given the new peer-reviewed data that the Spike-protein is produced in the body six months post-injection, we need to develop a strategy to remove these cells from the body. Igor Chudov’s substack does an excellent and concise job of describing how scientist discovered that people can become Spike-protein factories.
An FLCCC alliance podcast goes over the advantages of intermittent fasting as a method to clear the Spike -protein.
All About Autophagy and Clearing Spike Protein: FLCCC Weekly Update (July 13, 2022)
The induction of autophagy, due to fasting and intermittent fasting, clears out old and damaged cells. It also induced a priming of the immune system!! Early work, during the start of the plandemic, demonstrated that intermittent fasting can clear infected cells and boost the immune system. In the article Intermittent fasting, a possible priming tool for host defense against SARS-CoV-2 infection: Crosstalk among calorie restriction, autophagy and immune response, the authors outlined the great advantage to protect against SARs-CoV-2.
N-acetyl cysteine (NAC)
Early on NAC was identified as an agent against SARs-Cov-2:
“Proteomics data showed that N-acetyl cysteine (NAC), an antioxidant and mucolytic agent been widely in use in clinical medicine, forms covalent conjugates with solvent accessible cysteine residues of spike protein that were disulfide bonded in the native state…Antiviral assay using VeroE6 cells showed that NAC caused 54.3% inhibition in SARS-CoV-2 replication.” - N-acetyl cysteine: A tool to perturb SARS-CoV-2 spike protein conformation
This was followed up by various clinical trials to determine if NAC was a treatment against SAR-CoV-2 infections. Turns out it was protective and reduced mortality, especially in patients with co-morbidities.
“Our study found that NAC administered orally at a high dose was associated with better survival when added to standard treatment in patients with COVID 19 hospitalized with pneumonia. Despite admitted COVID-19 patients treated with NAC being older, more frequently male and had more comorbidities, the signal of an association with reduced mortality was strong for NAC and sustained in multivariate analysis.” - Use of N-Acetylcysteine at high doses as an oral treatment for patients hospitalized with COVID-19
Given that NAC attacks the Spike-protein directly, it should be part of the treatment routine for detox. There are online doctors (this is not an endorsement, but to be used as a comparative reference) that have developed similar processes to support Spike protein clearing.
As always, do your own research and get second opinions from your trusted health advisors.
Until next time.
BTW - I am not a doctor. I am not a licensed physician. This is opinion and should not be taken as medical advices.